Stock Alert: Mirati Up 15% On Positive Outcome For Its Adagrasib

(RTTNews) - Mirati Therapeutics, Inc. (MRTX) shares are rising on Monday morning trade as the clinical-stage oncology company presented deep and durable anti-tumor activity for Adagrasib in non-small cell lung cancer, colorectal cancer, and other solid tumors.

Currently, the shares are at $210.46, up 15.12 percent from its previous close of $180.20.

The shares have traded in a range of $66.01 to $210.00 on average volume of 418,534.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More